Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Molecular mimicry between tumor associated antigens and microbiota-derived epitopes
Concetta Ragone, Carmen Manolio, Angela Mauriello, et al.
Journal of Translational Medicine (2022) Vol. 20, Iss. 1
Open Access | Times Cited: 28

Showing 1-25 of 28 citing articles:

Peptide-based vaccine for cancer therapies
Luigi Buonaguro, Maria Tagliamonte
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 40
Exploiting bacteria for cancer immunotherapy
Seong Young Kwon, Hien Thi-Thu Ngo, Jinbae Son, et al.
Nature Reviews Clinical Oncology (2024) Vol. 21, Iss. 8, pp. 569-589
Closed Access | Times Cited: 40
Non-mutational neoantigens in disease
Lawrence J. Stern, Cristina C. Clement, Lorenzo Galluzzi, et al.
Nature Immunology (2024) Vol. 25, Iss. 1, pp. 29-40
Open Access | Times Cited: 21
Molecular mimicry and cancer vaccine development
Maria Tagliamonte, Beatrice Cavalluzzo, Angela Mauriello, et al.
Molecular Cancer (2023) Vol. 22, Iss. 1
Open Access | Times Cited: 29
Bacterial extracellular vesicles and their interplay with the immune system
Étienne Doré, Éric Boilard
Pharmacology & Therapeutics (2023) Vol. 247, pp. 108443-108443
Closed Access | Times Cited: 24
The intratumoral microbiota: friend or foe?
Valentina Ferrari, María Rescigno
Trends in cancer (2023) Vol. 9, Iss. 6, pp. 472-479
Closed Access | Times Cited: 18
The role of the sex hormone-gut microbiome axis in tumor immunotherapy
Luoyang Wang, Lei Tang, Dongchang Zhai, et al.
Gut Microbes (2023) Vol. 15, Iss. 1
Open Access | Times Cited: 17
Cross-reactive CD8+ T cell responses to tumor-associated antigens (TAAs) and homologous microbiota-derived antigens (MoAs)
Beatrice Cavalluzzo, Marie Christine Viuff, Siri Tvingsholm, et al.
Journal of Experimental & Clinical Cancer Research (2024) Vol. 43, Iss. 1
Open Access | Times Cited: 6
Microbes in the tumor microenvironment: New Additions to break the Tumor Immunotherapy Dilemma
Lujia Zhou, Shiying Fan, Wenjie Zhang, et al.
Microbiological Research (2024) Vol. 285, pp. 127777-127777
Closed Access | Times Cited: 5
Gut microbiome and tumor immunotherapy
Mohini Vig, Shweta Dubey
International review of cell and molecular biology (2025)
Closed Access
Microorganisms-derived antigens for preventive anti-cancer vaccines
Luigi Buonaguro, Beatrice Cavalluzzo, Angela Mauriello, et al.
Molecular Aspects of Medicine (2023) Vol. 92, pp. 101192-101192
Closed Access | Times Cited: 9
The good and the bad of T cell cross-reactivity: challenges and opportunities for novel therapeutics in autoimmunity and cancer
Cécile Gouttefangeas, Reinhild Klein, Ana Maia
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 9
Modulation of gut microbiota: a novel approach to enhancing the effects of immune checkpoint inhibitors
Jinglong Huang, Caifeng Gong, Aiping Zhou
Therapeutic Advances in Medical Oncology (2023) Vol. 15
Open Access | Times Cited: 9
Modulation of the Immune Environment in Glioblastoma by the Gut Microbiota
George B. H. Green, Alexis N. Cox-Holmes, Anna Claire E. Potier, et al.
Biomedicines (2024) Vol. 12, Iss. 11, pp. 2429-2429
Open Access | Times Cited: 2
Longitudinal analysis of the gut microbiota during anti-PD-1 therapy reveals stable microbial features of response in melanoma patients
Angeli D. Macandog, Carlotta Catozzi, Mariaelena Capone, et al.
Cell Host & Microbe (2024) Vol. 32, Iss. 11, pp. 2004-2018.e9
Open Access | Times Cited: 2
Gut microbiome in multiple myeloma: Mechanisms of progression and clinical applications
Liuyun Zhang, Yunhui Xiang, Yanying Li, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 11
Biomarker-Driven Personalization of Neoadjuvant Immunotherapy in Melanoma
Lotte Hoeijmakers, Irene L. M. Reijers, Christian U. Blank
Cancer Discovery (2023) Vol. 13, Iss. 11, pp. 2319-2338
Closed Access | Times Cited: 6
Promising and Minimally Invasive Biomarkers: Targeting Melanoma
Pavlina Spiliopoulou, Carlos Diego Holanda Lopes, Anna Spreafico
Cells (2023) Vol. 13, Iss. 1, pp. 19-19
Open Access | Times Cited: 6
Regulation of T cell repertoires by commensal microbiota
Kwang Soon Kim
Frontiers in Cellular and Infection Microbiology (2022) Vol. 12
Open Access | Times Cited: 10
Revamping Hepatocellular Carcinoma Immunotherapy: The Advent of Microbial Neoantigen Vaccines
Junze Liang, Yanxia Liao, Zhiwei Tu, et al.
Vaccines (2024) Vol. 12, Iss. 8, pp. 930-930
Open Access | Times Cited: 1
The impact of antigenic molecular mimicry on anti-cancer T-cell immune response
Maria Tagliamonte, Luigi Buonaguro
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 6
Integration: Gospel for immune bioinformatician on epitope-based therapy
Baozeng Sun, Junqi Zhang, Zhikui Li, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 3
The Value of Microbes in Cancer Neoantigen Immunotherapy
Junrui Tian, Jian Ma
Pharmaceutics (2023) Vol. 15, Iss. 8, pp. 2138-2138
Open Access | Times Cited: 3
Local Delivery of Immunomodulatory Antibodies for Gastrointestinal Tumors
Noelia Silva-Pilipich, Ángela Covo-Vergara, Cristian Smerdou
Cancers (2023) Vol. 15, Iss. 8, pp. 2352-2352
Open Access | Times Cited: 2
Molecular mimicry of SARS-COV-2 antigens as a possible natural anti-cancer preventive immunization
Concetta Ragone, Angela Mauriello, Beatrice Cavalluzzo, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access
Page 1 - Next Page

Scroll to top